Immutep Limited (PBMD) is traded on NASDAQ General Markets in USA. It is located in Sydney, NSW and employs 31 people. The company currently falls under 'Micro-Cap
' category with current market capitalization of 46.7 M. Immutep Limited has 0 outstanding shares of which 137.1 K shares are at this time shorted by private and institutional investors with about 1.25 trading days to cover.
Prima BioMed Ltd currently holds about 9.74 M in cash with (6.77 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.41.
Check Immutep Limited Probability Of Bankruptcy